TrialJournal of human hypertension2004

Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.

H A Punzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.